カテゴリ： 世界, 医療/バイオ, QYResearch

静脈血栓塞栓症予防の世界市場2023年：下肢、上肢

■ 英語タイトル：Global Venous Thromboembolism Prophylaxis Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8493）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8493
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[静脈血栓塞栓症予防の世界市場2023年：下肢、上肢]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は静脈血栓塞栓症予防のグローバル市場について調査・分析し、世界の静脈血栓塞栓症予防市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（下肢、上肢）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Arjo、Encompass Group、Talley Group、MEGO AFEK、Zenith Technical Innovations、Normatec、Bio Compression Systems、ThermoTek USAなどが含まれています。静脈血栓塞栓症予防のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、静脈血栓塞栓症予防市場規模を算出する際に考慮しました。

・静脈血栓塞栓症予防市場の概要
- 製品の定義
- 静脈血栓塞栓症予防の種類別セグメント
- 世界の静脈血栓塞栓症予防市場規模：タイプ別分析（下肢、上肢）
- 静脈血栓塞栓症予防の用途別セグメント
- 世界の静脈血栓塞栓症予防市場規模：用途別分析（病院、クリニック、その他）
- 世界の静脈血栓塞栓症予防市場規模予測（2018年-2029年）
- 静脈血栓塞栓症予防の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 静脈血栓塞栓症予防市場の競争状況およびトレンド

・静脈血栓塞栓症予防の地域別市場規模
- 北米の静脈血栓塞栓症予防市場規模（2018年-2029年）
- 米国の静脈血栓塞栓症予防市場規模（2018年-2029年）
- ヨーロッパの静脈血栓塞栓症予防市場規模（2018年-2029年）
- アジア太平洋の静脈血栓塞栓症予防市場規模（2018年-2029年）
- 中国の静脈血栓塞栓症予防市場規模（2018年-2029年）
- 日本の静脈血栓塞栓症予防市場規模（2018年-2029年）
- 韓国の静脈血栓塞栓症予防市場規模（2018年-2029年）
- インドの静脈血栓塞栓症予防市場規模（2018年-2029年）
- オーストラリアの静脈血栓塞栓症予防市場規模（2018年-2029年）
- 中南米の静脈血栓塞栓症予防市場規模（2018年-2029年）
- 中東・アフリカの静脈血栓塞栓症予防市場規模（2018年-2029年）

・種類別セグメント：下肢、上肢
- 世界の静脈血栓塞栓症予防のタイプ別販売量（2018年-2023年）
- 世界の静脈血栓塞栓症予防のタイプ別売上（2018年-2023年）
- 世界の静脈血栓塞栓症予防のタイプ別価格

・用途別セグメント：病院、クリニック、その他
- 世界の静脈血栓塞栓症予防の用途別販売量（2018年-2023年）
- 世界の静脈血栓塞栓症予防の用途別売上（2018年-2023年）
- 世界の静脈血栓塞栓症予防の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Arjo、Encompass Group、Talley Group、MEGO AFEK、Zenith Technical Innovations、Normatec、Bio Compression Systems、ThermoTek USA

・産業チェーンと販売チャネルの分析
- 静脈血栓塞栓症予防産業チェーン分析
- 静脈血栓塞栓症予防の主要原材料
- 静脈血栓塞栓症予防の販売チャネル
- 静脈血栓塞栓症予防のディストリビューター
- 静脈血栓塞栓症予防の主要顧客

・静脈血栓塞栓症予防市場ダイナミクス
- 静脈血栓塞栓症予防の業界動向
- 静脈血栓塞栓症予防市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Venous Thromboembolism Prophylaxis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Venous Thromboembolism Prophylaxis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Venous Thromboembolism Prophylaxis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Venous Thromboembolism Prophylaxis include Arjo, Encompass Group, Talley Group, MEGO AFEK, Zenith Technical Innovations, Normatec, Bio Compression Systems and ThermoTek USA, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Prophylaxis.
The Venous Thromboembolism Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Venous Thromboembolism Prophylaxis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Arjo
Encompass Group
Talley Group
MEGO AFEK
Zenith Technical Innovations
Normatec
Bio Compression Systems
ThermoTek USA
Segment by Type
Lower Extremity
Upper Extremity
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Venous Thromboembolism Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Venous Thromboembolism Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Venous Thromboembolism Prophylaxis Market Overview
1.1 Product Overview and Scope of Venous Thromboembolism Prophylaxis
1.2 Venous Thromboembolism Prophylaxis Segment by Type
1.2.1 Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2023-2029)
1.2.2 Lower Extremity
1.2.3 Upper Extremity
1.3 Venous Thromboembolism Prophylaxis Segment by Application
1.3.1 Global Venous Thromboembolism Prophylaxis Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Venous Thromboembolism Prophylaxis Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Prophylaxis Revenue 2018-2029
1.4.2 Global Venous Thromboembolism Prophylaxis Sales 2018-2029
1.4.3 Global Venous Thromboembolism Prophylaxis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Venous Thromboembolism Prophylaxis Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Venous Thromboembolism Prophylaxis Average Price by Manufacturers (2018-2023)
2.4 Global Venous Thromboembolism Prophylaxis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Type & Application
2.7 Venous Thromboembolism Prophylaxis Market Competitive Situation and Trends
2.7.1 Venous Thromboembolism Prophylaxis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism Prophylaxis Players Market Share by Revenue
2.7.3 Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Venous Thromboembolism Prophylaxis Retrospective Market Scenario by Region
3.1 Global Venous Thromboembolism Prophylaxis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Venous Thromboembolism Prophylaxis Global Venous Thromboembolism Prophylaxis Sales by Region: 2018-2029
3.2.1 Global Venous Thromboembolism Prophylaxis Sales by Region: 2018-2023
3.2.2 Global Venous Thromboembolism Prophylaxis Sales by Region: 2024-2029
3.3 Global Venous Thromboembolism Prophylaxis Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018-2029
3.3.1 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018-2023
3.3.2 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2024-2029
3.4 North America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.4.1 North America Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.4.3 North America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.5.1 Europe Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.5.3 Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.6.1 Asia Pacific Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.6.3 Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.7.1 Latin America Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.7.3 Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.8.1 Middle East and Africa Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
4.1.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2023)
4.1.2 Global Venous Thromboembolism Prophylaxis Sales by Type (2024-2029)
4.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
4.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
4.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023)
4.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029)
4.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
4.3 Global Venous Thromboembolism Prophylaxis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
5.1.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2023)
5.1.2 Global Venous Thromboembolism Prophylaxis Sales by Application (2024-2029)
5.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
5.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
5.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023)
5.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029)
5.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
5.3 Global Venous Thromboembolism Prophylaxis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Arjo
6.1.1 Arjo Corporation Information
6.1.2 Arjo Description and Business Overview
6.1.3 Arjo Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Arjo Venous Thromboembolism Prophylaxis Product Portfolio
6.1.5 Arjo Recent Developments/Updates
6.2 Encompass Group
6.2.1 Encompass Group Corporation Information
6.2.2 Encompass Group Description and Business Overview
6.2.3 Encompass Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Encompass Group Venous Thromboembolism Prophylaxis Product Portfolio
6.2.5 Encompass Group Recent Developments/Updates
6.3 Talley Group
6.3.1 Talley Group Corporation Information
6.3.2 Talley Group Description and Business Overview
6.3.3 Talley Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Talley Group Venous Thromboembolism Prophylaxis Product Portfolio
6.3.5 Talley Group Recent Developments/Updates
6.4 MEGO AFEK
6.4.1 MEGO AFEK Corporation Information
6.4.2 MEGO AFEK Description and Business Overview
6.4.3 MEGO AFEK Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MEGO AFEK Venous Thromboembolism Prophylaxis Product Portfolio
6.4.5 MEGO AFEK Recent Developments/Updates
6.5 Zenith Technical Innovations
6.5.1 Zenith Technical Innovations Corporation Information
6.5.2 Zenith Technical Innovations Description and Business Overview
6.5.3 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Portfolio
6.5.5 Zenith Technical Innovations Recent Developments/Updates
6.6 Normatec
6.6.1 Normatec Corporation Information
6.6.2 Normatec Description and Business Overview
6.6.3 Normatec Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Normatec Venous Thromboembolism Prophylaxis Product Portfolio
6.6.5 Normatec Recent Developments/Updates
6.7 Bio Compression Systems
6.6.1 Bio Compression Systems Corporation Information
6.6.2 Bio Compression Systems Description and Business Overview
6.6.3 Bio Compression Systems Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio Compression Systems Venous Thromboembolism Prophylaxis Product Portfolio
6.7.5 Bio Compression Systems Recent Developments/Updates
6.8 ThermoTek USA
6.8.1 ThermoTek USA Corporation Information
6.8.2 ThermoTek USA Description and Business Overview
6.8.3 ThermoTek USA Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ThermoTek USA Venous Thromboembolism Prophylaxis Product Portfolio
6.8.5 ThermoTek USA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venous Thromboembolism Prophylaxis Industry Chain Analysis
7.2 Venous Thromboembolism Prophylaxis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venous Thromboembolism Prophylaxis Production Mode & Process
7.4 Venous Thromboembolism Prophylaxis Sales and Marketing
7.4.1 Venous Thromboembolism Prophylaxis Sales Channels
7.4.2 Venous Thromboembolism Prophylaxis Distributors
7.5 Venous Thromboembolism Prophylaxis Customers
8 Venous Thromboembolism Prophylaxis Market Dynamics
8.1 Venous Thromboembolism Prophylaxis Industry Trends
8.2 Venous Thromboembolism Prophylaxis Market Drivers
8.3 Venous Thromboembolism Prophylaxis Market Challenges
8.4 Venous Thromboembolism Prophylaxis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Venous Thromboembolism Prophylaxis Market Competitive Situation by Manufacturers in 2022
Table 4. Global Venous Thromboembolism Prophylaxis Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Venous Thromboembolism Prophylaxis Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Type & Application
Table 12. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Venous Thromboembolism Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Prophylaxis as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Venous Thromboembolism Prophylaxis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 18. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2023)
Table 19. Global Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 20. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2024-2029)
Table 21. Global Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2023)
Table 23. Global Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2024-2029)
Table 25. North America Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 27. North America Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 28. North America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 32. Europe Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 33. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Type (2018-2023)
Table 51. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Type (2024-2029)
Table 52. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2023)
Table 53. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2024-2029)
Table 54. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2023)
Table 57. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2024-2029)
Table 58. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2018-2023)
Table 59. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2024-2029)
Table 60. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Application (2018-2023)
Table 61. Global Venous Thromboembolism Prophylaxis Sales (K Units) by Application (2024-2029)
Table 62. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2023)
Table 63. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2024-2029)
Table 64. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Venous Thromboembolism Prophylaxis Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2023)
Table 67. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2024-2029)
Table 68. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2018-2023)
Table 69. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2024-2029)
Table 70. Arjo Corporation Information
Table 71. Arjo Description and Business Overview
Table 72. Arjo Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Arjo Venous Thromboembolism Prophylaxis Product
Table 74. Arjo Recent Developments/Updates
Table 75. Encompass Group Corporation Information
Table 76. Encompass Group Description and Business Overview
Table 77. Encompass Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Encompass Group Venous Thromboembolism Prophylaxis Product
Table 79. Encompass Group Recent Developments/Updates
Table 80. Talley Group Corporation Information
Table 81. Talley Group Description and Business Overview
Table 82. Talley Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Talley Group Venous Thromboembolism Prophylaxis Product
Table 84. Talley Group Recent Developments/Updates
Table 85. MEGO AFEK Corporation Information
Table 86. MEGO AFEK Description and Business Overview
Table 87. MEGO AFEK Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. MEGO AFEK Venous Thromboembolism Prophylaxis Product
Table 89. MEGO AFEK Recent Developments/Updates
Table 90. Zenith Technical Innovations Corporation Information
Table 91. Zenith Technical Innovations Description and Business Overview
Table 92. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product
Table 94. Zenith Technical Innovations Recent Developments/Updates
Table 95. Normatec Corporation Information
Table 96. Normatec Description and Business Overview
Table 97. Normatec Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Normatec Venous Thromboembolism Prophylaxis Product
Table 99. Normatec Recent Developments/Updates
Table 100. Bio Compression Systems Corporation Information
Table 101. Bio Compression Systems Description and Business Overview
Table 102. Bio Compression Systems Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Bio Compression Systems Venous Thromboembolism Prophylaxis Product
Table 104. Bio Compression Systems Recent Developments/Updates
Table 105. ThermoTek USA Corporation Information
Table 106. ThermoTek USA Description and Business Overview
Table 107. ThermoTek USA Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ThermoTek USA Venous Thromboembolism Prophylaxis Product
Table 109. ThermoTek USA Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Venous Thromboembolism Prophylaxis Distributors List
Table 113. Venous Thromboembolism Prophylaxis Customers List
Table 114. Venous Thromboembolism Prophylaxis Market Trends
Table 115. Venous Thromboembolism Prophylaxis Market Drivers
Table 116. Venous Thromboembolism Prophylaxis Market Challenges
Table 117. Venous Thromboembolism Prophylaxis Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Venous Thromboembolism Prophylaxis
Figure 2. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Venous Thromboembolism Prophylaxis Market Share by Type in 2022 & 2029
Figure 4. Lower Extremity Product Picture
Figure 5. Upper Extremity Product Picture
Figure 6. Global Venous Thromboembolism Prophylaxis Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Venous Thromboembolism Prophylaxis Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Venous Thromboembolism Prophylaxis Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Venous Thromboembolism Prophylaxis Market Size (2018-2029) & (US$ Million)
Figure 13. Global Venous Thromboembolism Prophylaxis Sales (2018-2029) & (K Units)
Figure 14. Global Venous Thromboembolism Prophylaxis Average Price (US$/Unit) & (2018-2029)
Figure 15. Venous Thromboembolism Prophylaxis Report Years Considered
Figure 16. Venous Thromboembolism Prophylaxis Sales Share by Manufacturers in 2022
Figure 17. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Venous Thromboembolism Prophylaxis Players: Market Share by Revenue in 2022
Figure 19. Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Venous Thromboembolism Prophylaxis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Venous Thromboembolism Prophylaxis Sales Market Share by Country (2018-2029)
Figure 22. North America Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2018-2029)
Figure 23. United States Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Country (2018-2029)
Figure 26. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2018-2029)
Figure 27. Germany Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2029)
Figure 34. China Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Country (2018-2029)
Figure 44. Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Venous Thromboembolism Prophylaxis Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Venous Thromboembolism Prophylaxis Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Venous Thromboembolism Prophylaxis Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Venous Thromboembolism Prophylaxis by Type (2018-2029)
Figure 54. Global Revenue Market Share of Venous Thromboembolism Prophylaxis by Type (2018-2029)
Figure 55. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Venous Thromboembolism Prophylaxis by Application (2018-2029)
Figure 57. Global Revenue Market Share of Venous Thromboembolism Prophylaxis by Application (2018-2029)
Figure 58. Global Venous Thromboembolism Prophylaxis Price (US$/Unit) by Application (2018-2029)
Figure 59. Venous Thromboembolism Prophylaxis Value Chain
Figure 60. Venous Thromboembolism Prophylaxis Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 臓器拒絶反応予防薬のグローバル市場展望 2023年-2029年：内服液、注射剤、カプセル
  • 静脈逆流症治療の世界市場2023年：手術治療、非外科的治療
  • 静脈穿刺装置の世界市場2023年：注射針、注射器、真空チューブ、その他
  • 静脈フットポンプの世界市場2023年：卓上、縦型
  • 末梢静脈カテーテルの世界市場2023年：テンポラリーカテーテル、ショートタームカテーテル、ロングタームカテーテル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8493 )"静脈血栓塞栓症予防の世界市場2023年：下肢、上肢" (英文：Global Venous Thromboembolism Prophylaxis Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。